Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Chittenden

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Pharmaceutical Sciences|November 1, 2013
Modeling of pharmacokinetic systems using stochastic deconvolutionMaziar Kakhi, Jason Chittenden
International Journal of Pharmaceutics|June 29, 2026
Erratum to "In vitro - In vivo correlation modeling of an oxcarbezapine extended-release formulation using numerical deconvolution" [Int. J. Pharm. 699 (2026) 126952]Maziar Kakhi, Hansong Chen, Jason Chittenden
International Journal of Pharmaceutics|May 17, 2026
In vitro - In vivo correlation modeling of an oxcarbezapine extended-release formulation using numerical deconvolutionMaziar Kakhi, Hansong Chen, Jason Chittenden
Biopharmaceutics & Drug Disposition|October 26, 2012
Analysis of level A in vitro-in vivo correlations for an extended-release formulation with limited bioavailabilityMaziar Kakhi, Patrick Marroum, Jason Chittenden
Journal of Pharmacokinetics and Pharmacodynamics|November 21, 2015
Stochastic nonlinear mixed effects: a metformin case studyBrett Matzuka, Jason Chittenden, Jonathan Monteleone, et al.
Journal of Pharmaceutical Sciences|March 26, 2017
Application of an NLME-Stochastic Deconvolution Approach to Level A IVIVC ModelingMaziar Kakhi, Sandra Suarez-Sharp, Terry Shepard, et al.
Cancer Chemotherapy and Pharmacology|December 28, 2014
Onartuzumab with or without bevacizumab in combination with weekly paclitaxel does not prolong QTc or adversely affect other ECG parameters in patients with locally recurrent or metastatic triple-negative breast cancerMarie T Borin, Meng Chen, Simonetta Mocci, et al.
Computer Methods and Programs in Biomedicine|March 4, 2017
Phxnlme: An R package that facilitates pharmacometric workflow of Phoenix NLME analysesChay Ngee Lim, Shuang Liang, Kevin Feng, et al.
Journal of Clinical Pharmacology|November 9, 2024
A Phase I Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Liposomal Bupivacaine for Sciatic Nerve Block in the Popliteal Fossa for BunionectomyDaniel I Sessler, Xiaodong Bao, David Leiman, et al.
Clinical Pharmacology and Therapeutics|February 26, 2026
Population Pharmacokinetics of Dupilumab in Adults, Adolescents, and Children With Eosinophilic EsophagitisJenny-Hoa Nguyen, Mirna Chehade, Evan S Dellon, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Pharmaceutical Sciences|November 1, 2013
Modeling of pharmacokinetic systems using stochastic deconvolutionMaziar Kakhi, Jason Chittenden
International Journal of Pharmaceutics|June 29, 2026
Erratum to "In vitro - In vivo correlation modeling of an oxcarbezapine extended-release formulation using numerical deconvolution" [Int. J. Pharm. 699 (2026) 126952]Maziar Kakhi, Hansong Chen, Jason Chittenden
International Journal of Pharmaceutics|May 17, 2026
In vitro - In vivo correlation modeling of an oxcarbezapine extended-release formulation using numerical deconvolutionMaziar Kakhi, Hansong Chen, Jason Chittenden
Biopharmaceutics & Drug Disposition|October 26, 2012
Analysis of level A in vitro-in vivo correlations for an extended-release formulation with limited bioavailabilityMaziar Kakhi, Patrick Marroum, Jason Chittenden
Journal of Pharmacokinetics and Pharmacodynamics|November 21, 2015
Stochastic nonlinear mixed effects: a metformin case studyBrett Matzuka, Jason Chittenden, Jonathan Monteleone, et al.
Journal of Pharmaceutical Sciences|March 26, 2017
Application of an NLME-Stochastic Deconvolution Approach to Level A IVIVC ModelingMaziar Kakhi, Sandra Suarez-Sharp, Terry Shepard, et al.
Cancer Chemotherapy and Pharmacology|December 28, 2014
Onartuzumab with or without bevacizumab in combination with weekly paclitaxel does not prolong QTc or adversely affect other ECG parameters in patients with locally recurrent or metastatic triple-negative breast cancerMarie T Borin, Meng Chen, Simonetta Mocci, et al.
Computer Methods and Programs in Biomedicine|March 4, 2017
Phxnlme: An R package that facilitates pharmacometric workflow of Phoenix NLME analysesChay Ngee Lim, Shuang Liang, Kevin Feng, et al.
Journal of Clinical Pharmacology|November 9, 2024
A Phase I Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Liposomal Bupivacaine for Sciatic Nerve Block in the Popliteal Fossa for BunionectomyDaniel I Sessler, Xiaodong Bao, David Leiman, et al.
Clinical Pharmacology and Therapeutics|February 26, 2026
Population Pharmacokinetics of Dupilumab in Adults, Adolescents, and Children With Eosinophilic EsophagitisJenny-Hoa Nguyen, Mirna Chehade, Evan S Dellon, et al.
Pageof 2